Inhibiting menin, a protein that supports leukemia growth and is already targeted to treat some forms of leukemia, also holds ...

This group of cancers remains a challenge to diagnose, can be rapidly progressive, and requires complex treatment and follow-up care, research suggests. Despite recent advancements in treatments for ...

There are promising drugs for myeloproliferative neoplasms coming down the pipeline. It is an exciting time for the treatment of myeloproliferative neoplasms (MPNs), as new treatments continue to ...

Please provide your email address to receive an email when new articles are posted on . John O. Mascarenhas, MD, spoke with Healio about a presentation given during the morning session at 14th ...

A new form of CAR T cell therapy has been designed to find and destroy the cancer-driving stem cells responsible for a group of blood cancers known as myeloproliferative neoplasms (MPNs), while ...

A decision to rename myeloproliferative neoplasms led to a plethora of developments in a space where there was once little interest. Name recognition. The term is often associated with Fortune 500 ...

Kristie L. Kahl: After receiving a diagnosis, what is the best way for patients to learn more about their disease? Dr. Ruben Mesa: Fortunately, there are some very high-quality materials out there.

Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. So in MPNs, and this is what I tell my ...

Myeloproliferative neoplasm symptoms vary depending on the type a person has. Some symptoms include fatigue, headaches, fever, and unintentional weight loss. There are six types of chronic ...

This project includes whole-genome and transcriptome sequencing of 5000 patients with hematological neoplasms and is funded by the Torsten Haferlach Leukämie Diagnostikstiftung.